Brain & Nervous System Multiple Sclerosis Symptoms Early Signs of Multiple Sclerosis (MS) By Colleen Doherty, MD Updated on January 07, 2025 Medically reviewed by David Ozeri, MD Print Table of Contents View All Table of Contents Clinically Isolated Syndrome Optic Neuritis Other Common Symptoms Males vs. Females Diagnosis Life Expectancy Early signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning signs occur because of damage to the fatty covering (myelin) that insulates nerve fibers within your central nervous system (CNS). Your immune system's attack on myelin changes how nerve signals are transmitted in the body. No two people experience multiple sclerosis (MS) in the same way, though an early episode called clinically isolated syndrome is common. So are vision changes. Symptoms like the "MS hug"— a squeezing feeling around the torso — occur in about 25% of cases and often are a first symptom of MS. If possible MS symptoms occur, see your healthcare provider. peakSTOCK / Getty Images Clinically Isolated Syndrome Clinically isolated syndrome (CIS) refers to a person's first-time episode of neurological symptoms caused by inflammation and damaged myelin in the CNS. The symptoms can occur within a few hours, or even take a week or two to develop if they affect the spinal cord. Symptoms can emerge in hours to days when vision is involved. As an example, a person diagnosed with CIS may experience numbness and tingling in their legs. This would be evaluated by magnetic resonance imaging (MRI) findings that reveal damage to the CNS. To be considered CIS, the episode: Must last at least 24 hoursBe caused by inflammation and damage to the myelin Other symptoms could include dizziness, facial numbness, and problems with gait (walking) and balance. CIS can be followed by a recovery period where the symptoms improve or completely go away. Ongoing research is identifying specific biomarkers that can help to understand who is more likely to develop MS after a CIS episode. Not everyone does, and there are treatments approved by the Food and Drug Administration to delay or prevent the progression of CIS to MS. Difference Between CIS and MS A CIS episode can mean you are at greater risk of developing MS. There is a 60% to 80% chance of another episode and an MS diagnosis within a few years if your MRI results show brain lesions consistent with MS. The chance of MS is about 20% if no lesions are found, and it isn't diagnosed until one or more episodes occur. Changes to cerebrospinal fluid (CSF) also are evaluated. Optic Neuritis Optic neuritis—inflammation of one of your two optic nerves—is a common first presentation of MS. In fact, CIS may be diagnosed from an attack of optic neuritis. Your optic nerve delivers messages to your brain about what your eye sees. When the myelin covering the optic nerve is damaged, signals related to sight are interrupted. The common symptoms of optic neuritis include: Blurry visionDim vision, as if the lights were turned downColor vision changes, especially red and greenPain in the back of your eye socketPain when you move your eyes A 2024 research report on 157 people who experienced a CIS episode found that 38% of them had optic neuritis as a first symptom. When they were followed up two years later (on average), 71% of them had been diagnosed with multiple sclerosis. Can You Have MS for Years and Not Know? Yes. In fact, research suggests MS may have a prodromal ("very early") phase. This phase includes various nonspecific symptoms, like fatigue, depression, pain, and headache. These symptoms may precede an MS diagnosis by several years. Other Common Symptoms Even though the symptoms of MS vary in type, severity, and duration, there are some that are more common than others. The following is a brief snapshot of such symptoms: Vision Problems Besides optic neuritis, other common vision problems seen in MS include the following: Nystagmus is uncontrolled, jerking movement of the eyes, sometimes referred to as "dancing eyes." This symptom is caused by damage to the area of the brainstem that controls eye movements.Diplopia (double vision) is uncoordinated eye movement that causes you to see double. This symptom results from damage to the nerves that control your eye muscles. Muscle Spasms Muscle spasms are common in MS and are primarily caused by damaged myelin in the nerves that innervate or connect to your muscles. As a result of disrupted nerve signals, your muscles cannot relax properly. This causes muscle stiffness and/or a tightening, cramping, or heavy sensation in the affected muscle(s). About 80% of people living with MS experience muscle spasms. The legs are most commonly affected by spasms, but they can occur anywhere in the body. Muscle spasms also tend to be asymmetric, meaning they are more likely to happen on one side of the body versus both sides. Pain Nerve fiber damage in MS causes neuropathic pain, which is associated with burning, stabbing, sharp, itching, or squeezing sensations. This type of pain is associated with disability, depression, and fatigue in MS. Specific types of neuropathic pain that may be early signs of MS include: Lhermitte's sign is a sensation of electricity that runs down your spine when you touch your chin to your chest. In MS, it's caused by damage to nerve fibers in your upper spine. MS hug is a tightening sensation around the chest and ribs caused by damage to the nerve fibers in your spine. Trigeminal neuralgia is an electric-shock-like or stabbing pain in the face or jaw area that is caused by damage to the trigeminal nerve (the fifth cranial nerve). Fatigue and Weakness MS fatigue is often felt both physically and mentally. Described by many as "having the flu," MS fatigue is not eased by sleep and tends to come on suddenly and worsen with heat and humidity. The overwhelming exhaustion and depletion of energy seen with MS fatigue may arise from the disease itself and/or other factors like medications, sleep disorders, or depression. Weakness is also common due to damage to the nerve fibers in the CNS that normally control muscle movements. Lack of activity due to MS-related pain, fatigue, or other symptoms can also contribute to MS weakness. Exercise can help some people to manage symptoms. Timeline of MS Fatigue People experience a wide range of fatigue symptoms in 75% or more of MS cases. It can occur at any time during the course of MS, and its development is not necessarily related to the progression of more objective neurological symptoms like walking problems. Bladder and Bowel Problems Bladder dysfunction is common in MS, affecting the majority of people at some point in the course of their disease. Urinary symptoms as the first presentation of MS occur in around 3% to 10% of people. Symptoms and signs of bladder dysfunction in MS vary from mild to severe. They may include: Urgency: Feeling like you have to urinate right awayHesitancy: Having trouble initiating urination or you cannot maintain a steady streamNocturia: Having to urinate often at nightIncontinence: Having an involuntary loss of urine control Recurrent urinary tract infections may also be a sign of bladder dysfunction in MS. Bowel problems are common in MS, with constipation a frequent complaint. Constipation can aggravate other MS symptoms including muscle spasms, pain, bladder dysfunction, and walking problems. It can also contribute to fecal incontinence, a loss of bowel control. Depression and Emotional Changes Depression is associated with constant sadness and a lack of interest in activities you once enjoyed. In MS, depression can occur at any time in the course of the disease, including early or later on. A 2024 study of more than 5,633 people living with MS found that one in four experienced depression. Depression in MS may stem from a number of different factors, including: MS itself: Damage to the areas of the brain that regulate emotion Side effects of MS medications: For example, corticosteroids (used to treat MS relapses) and interferon drugs (used as disease-modifying therapies) Stress associated with living with MS: Undergoing a new diagnosis, relapse, or major change in function. Anxiety and other common emotional symptoms and conditions also occur with MS. Many of these emotions stem from the unpredictable nature of MS, and the physical and emotional impact the disease. Presentation in Males vs. Females Differences exist in MS in males and females. For instance, research has found that females are twice as likely to live with MS as males. Moreover, those diagnosed with primary progressive MS (PPMS) are more likely to be male. What Is PPMS? PPMS is characterized by worsening symptoms from the onset of the disease. People with PPMS do not experience relapses or periods of symptom improvement ("remission"). In addition to PPMS, types include: Relapsing–remitting (RRMS) Secondary progressive (SPMS) Relapsing-progressive (RPMS) Experts haven't yet teased out fully why these differences between sexes exist. Sex hormones, pregnancy, social factors (delayed care-seeking behavior), and/or differences in genes or environmental exposures may be involved. Who's At Risk for Multiple Sclerosis? Females are more likely than males to develop MS, typically between the ages of 20 and 40. It can affect all racial and ethnic groups but is more common in White people. Risk factors can include:Certain genetic changes and a family history of MSA history of smokingVitamin D deficiencyCertain environmental exposuresUnderlying viral illness (Epstein Barr) or autoimmune disorder How MS Is Diagnosed The diagnosis of MS is often challenging, considering the symptoms are so variable. Symptoms can be similar to or mimic other conditions, like lupus (an autoimmune disease that can affect many body systems) or vitamin B12 deficiency. A neurologist—a doctor who specializes in diseases of the nervous system—will use the following tools to confirm a diagnosis of MS: Your medical history and neurological exam The McDonald criteria (a set of guidelines that focuses on diagnosing MS by showing evidence of damage to the CNS at different dates and to different parts) Magnetic resonance imaging (MRI) of the brain and spinal cord (which uses strong magnets to produce detailed images) Laboratory tests, mostly to rule out other conditions Other tests, including a spinal tap (lumbar puncture) and evoked potential tests (which measure electrical activity of the nerves of the eye) There is no blood test that can diagnose MS. Talk with your healthcare provider about diagnostic tools. Life Expectancy With MS Most people live full life spans while managing MS, which is a chronic disease. However, it is likely that their lives may be a few years shorter. A study from Norway that followed people for 60 years found that people with MS have an average life expectancy of 74.7 years, seven years less than the general population. Factors like overall health, access to MS treatment, and type of MS progression also influence life expectancy. For example, people with the RRMS type of MS tend to live longer than those diagnosed with the PPMS type, which has a poor prognosis. Summary Even though no two people experience MS in the same way, there are some symptoms, including vision problems and sensory disturbances, that may serve as early warning signs of the disease. Other common symptoms of MS include fatigue, muscle spasms, pain, bladder problems, and constipation. Keep in mind that many symptoms of MS can occur with other medical conditions. If you are concerned that you may be experiencing possible symptoms of MS, schedule an appointment with your healthcare provider or a neurologist. Diagnosing and treating MS as early as possible is associated with better long-term outcomes. 21 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. National Institute of Neurological Disorders and Stroke. Multiple Sclerosis. National Multiple Sclerosis Society. Multiple Sclerosis Symptoms. National Multiple Sclerosis Society. Clinically isolated syndrome. Probert F, Yeo T, Zhou Y, Sealey M, Arora S, Palace J, et al. Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis. Brain Commun. 2021 Apr 19;3(2):fcab084. doi:10.1093/braincomms/fcab084 Küchlin S, Ihorst G, Heinrich SP, Márquez Neila P, Albrecht P, Hug MJ, et al. Disease Course of Clinically Isolated Optic Neuritis. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200223. doi:10.1212/NXI.0000000000200223 American Academy of Ophthalmology. What Is Optic Neuritis? Johns Hopkins Medicine. Multiple Sclerosis (MS). Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castilló J, Moncho D, et al. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology. 2024 Jan 9;102(1):e200805. doi:10.1212/WNL.0000000000207805 DiSanto G, Zecca C, MacLachlan S et al. Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol 2018;83(6):1162-1173. doi:10.1002/ana.25247 Cavenaghi VB, Dobrianskyj FM, Sciascia do Olival G, Castello Dias Carneiro RP, Tilbery CP. Characterization of the first symptoms of multiple sclerosis in a Brazilian center: Cross-sectional study. Sao Paulo Med J. 2017;135(3):222-225. doi:10.1590/1516-3180.2016.0200270117 National Multiple Sclerosis Society. Vision disorders and multiple sclerosis. Cameron MH, Bethoux F, Field-Fote E, Lenderking WR, Zaiser E, Cutts KN, et al. Development of an integrated conceptual model of multiple sclerosis spasticity. Disabil Rehabil. 2024 Jun;46(13):2955-2965. doi:10.1080/09638288.2023.2237403 Shkodina AD, Bardhan M, Chopra H, Anyagwa OE, Pinchuk VA, Hryn KV, et al. Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis. CNS Drugs. 2024 Mar;38(3):205-224. doi:10.1007/s40263-024-01072-5 Wendebourg MJ, Poettgen J, Finlayson M, Gonzalez-Lorenzo M, Heesen C, Köpke S, et al. Education for fatigue management in people with multiple sclerosis: Systematic review and meta-analysis. Eur J Neurol. 2024 Dec;31(12):e16452. doi:10.1111/ene.16452 Aharony SM, Lam O, Corcos J. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines. Can Urol Assoc J. 2017;11(1-2):61–64. doi:10.5489/cuaj.4058 Young CA, Langdon D, Rog D, Chhetri SK, Tanasescu R, Kalra S, et al. Prevalence, treatment and correlates of depression in multiple sclerosis. Mult Scler Relat Disord. 2024 Jul;87:105648. doi:10.1016/j.msard.2024.105648 Walton C, Rechtman L. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020 Dec; 26(14): 1816–1821. doi:10.1177/1352458520970841 Sempik I, Dziadkowiak E, Moreira H, Zimny A, Pokryszko-Dragan A. Primary Progressive Multiple Sclerosis-A Key to Understanding and Managing Disease Progression. Int J Mol Sci. 2024 Aug 11;25(16):8751. doi:10.3390/ijms25168751 Eccles A. Delayed diagnosis of multiple sclerosis in males: May account for and dispel common understandings of different MS 'types.' Br J Gen Pract. 2019;69(680):148–149. doi:10.3399/bjgp19X701729 Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: Progress and challenges. Lancet. 2017;389(10076):1336-1346. doi:10.1016/S0140-6736(16)30959-X Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry. 2017;88(8):621-625. doi:10.1136/jnnp-2016-315238 By Colleen Doherty, MD Dr. Doherty is a board-certified internist and writer living with multiple sclerosis. She is based in Chicago. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit